$EVLO Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Evelo Biosciences, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Evelo Biosciences, Inc.. Get notifications about new insider transactions in Evelo Biosciences, Inc. for free.

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 03 2021	EVLO	Evelo Biosciences, ...	Scavo Luca	CFO	Option Exercise	A	0.00	4,545	0	4,545
Jun 03 2021	EVLO	Evelo Biosciences, ...	Scavo Luca	CFO	Option Exercise	A	14.24	300,000	4,272,000	300,000
Jun 03 2021	EVLO	Evelo Biosciences, ...	Scavo Luca	CFO	Option Exercise	A	0.00	4,545	0	4,545
Jun 03 2021	EVLO	Evelo Biosciences, ...	Scavo Luca	CFO	Option Exercise	A	14.24	300,000	4,272,000	300,000
Apr 13 2021	EVLO	Evelo Biosciences, ...	McHugh Julie	Director	Option Exercise	A	10.04	31,380	315,055	31,380
Feb 04 2021	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	15.00	46,429	696,435	4,125,461	4.1 M to 4.1 M (+1.14 %)
Feb 04 2021	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	15.00	37,143	557,145	1,370,476	1.3 M to 1.4 M (+2.79 %)
Feb 04 2021	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	15.00	9,285	139,275	791,529	782.2 K to 791.5 K (+1.19 %)
Feb 04 2021	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	15.00	37,143	557,145	3,207,312	3.2 M to 3.2 M (+1.17 %)
Jan 29 2021	EVLO	Evelo Biosciences, ...	GILL SIMBA	President & CEO	Option Exercise	A	16.65	275,000	4,578,750	275,000
Jan 29 2021	EVLO	Evelo Biosciences, ...	Hohneker John	Director	Option Exercise	A	16.65	31,380	522,477	31,380
Jan 29 2021	EVLO	Evelo Biosciences, ...	Bodmer Mark	CSO, President of R ...	Option Exercise	A	16.65	179,000	2,980,350	179,000
Jan 29 2021	EVLO	Evelo Biosciences, ...	McHale Duncan	Chief Medical Offic ...	Option Exercise	A	16.65	96,500	1,606,725	96,500
Jan 29 2021	EVLO	Evelo Biosciences, ...	Liu Xiaoli Jacqueline	Principal Accountin ...	Option Exercise	A	0.00	5,680	0	5,680
Jan 29 2021	EVLO	Evelo Biosciences, ...	Liu Xiaoli Jacqueline	Principal Accountin ...	Option Exercise	A	16.65	24,000	399,600	24,000
Jan 29 2021	EVLO	Evelo Biosciences, ...	Char Daniel	General Counsel	Option Exercise	A	16.65	57,000	949,050	57,000
Jan 29 2021	EVLO	Evelo Biosciences, ...	Zung Jonathan B.	Chief Development O ...	Option Exercise	A	16.65	300,000	4,995,000	300,000
Dec 14 2020	EVLO	Evelo Biosciences, ...	Epstein David R	Director	Buy	P	7.02	200	1,404	17,700	17.5 K to 17.7 K (+1.14 %)
Dec 14 2020	EVLO	Evelo Biosciences, ...	Epstein David R	Director	Buy	P	6.98	500	3,490	17,500	17 K to 17.5 K (+2.94 %)
Dec 14 2020	EVLO	Evelo Biosciences, ...	Epstein David R	Director	Buy	P	6.91	1,000	6,910	17,000	16 K to 17 K (+6.25 %)
Dec 14 2020	EVLO	Evelo Biosciences, ...	Epstein David R	Director	Buy	P	7.16	800	5,728	16,000	15.2 K to 16 K (+5.26 %)
Dec 14 2020	EVLO	Evelo Biosciences, ...	Epstein David R	Director	Buy	P	6.49	4,970	32,255	15,200	10.2 K to 15.2 K (+48.58 %)
Dec 14 2020	EVLO	Evelo Biosciences, ...	Epstein David R	Director	Buy	P	6.45	30	194	10,230	10.2 K to 10.2 K (+0.29 %)
Dec 14 2020	EVLO	Evelo Biosciences, ...	Epstein David R	Director	Buy	P	6.40	200	1,280	10,200	10 K to 10.2 K (+2.00 %)
Dec 02 2020	EVLO	Evelo Biosciences, ...	Liu Xiaoli Jacqueline	Principal Accountin ...	Sell	S	5.17	3,000	15,510	0	3 K to 0 (-100.00 %)
Oct 14 2020	EVLO	Evelo Biosciences, ...	Epstein David R	Director	Option Exercise	A	5.66	44,743	253,245	44,743
Oct 14 2020	EVLO	Evelo Biosciences, ...	Epstein David R	Director	Option Exercise	A	5.66	59,395	336,176	59,395
Sep 01 2020	EVLO	Evelo Biosciences, ...	Epstein David R	Director	Buy	P	4.58	1,000	4,580	10,000	9 K to 10 K (+11.11 %)
Sep 01 2020	EVLO	Evelo Biosciences, ...	Epstein David R	Director	Buy	P	4.48	1,000	4,480	9,000	8 K to 9 K (+12.50 %)
Sep 01 2020	EVLO	Evelo Biosciences, ...	Epstein David R	Director	Buy	P	4.47	1,000	4,470	8,000	7 K to 8 K (+14.29 %)
Sep 01 2020	EVLO	Evelo Biosciences, ...	Epstein David R	Director	Buy	P	4.46	2,752	12,274	7,000	4.2 K to 7 K (+64.78 %)
Sep 01 2020	EVLO	Evelo Biosciences, ...	Epstein David R	Director	Buy	P	4.40	3,248	14,291	4,248	1,000 to 4.2 K (+324.80 %)
Sep 01 2020	EVLO	Evelo Biosciences, ...	Epstein David R	Director	Buy	P	4.34	1,000	4,340	1,000	0 to 1,000
Jul 14 2020	EVLO	Evelo Biosciences, ...	Liu Xiaoli Jacqueline	Principal Accountin ...	Option Exercise	A	4.20	30,000	126,000	30,000
Jul 01 2020	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	3.75	1,666,667	6,250,001	4,079,032	2.4 M to 4.1 M (+69.09 %)
Jul 01 2020	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	3.75	1,333,333	4,999,999	1,333,333	0 to 1.3 M
Jul 01 2020	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	3.75	333,333	1,249,999	782,244	448.9 K to 782.2 K (+74.25 %)
Jul 01 2020	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	3.75	1,333,333	4,999,999	3,170,169	1.8 M to 3.2 M (+72.59 %)
Jun 18 2020	EVLO	Evelo Biosciences, ...	Simonian Nancy A	Director	Option Exercise	A	3.59	15,690	56,327	15,690
Jun 18 2020	EVLO	Evelo Biosciences, ...	MELAS KYRIAZI THEO	Director	Option Exercise	A	3.59	15,690	56,327	15,690
Jun 18 2020	EVLO	Evelo Biosciences, ...	Darzi Lord Ara	Director	Option Exercise	A	3.59	15,690	56,327	15,690
Jun 18 2020	EVLO	Evelo Biosciences, ...	PERRY DAVID P	Director	Option Exercise	A	3.59	15,690	56,327	15,690
Jun 18 2020	EVLO	Evelo Biosciences, ...	Andres Juan	Director	Option Exercise	A	3.59	15,690	56,327	15,690
Apr 10 2020	EVLO	Evelo Biosciences, ...	Graham Neil	Chief Development O ...	Option Exercise	A	3.72	150,000	558,000	150,000
Apr 10 2020	EVLO	Evelo Biosciences, ...	Graham Neil	Chief Development O ...	Option Exercise	A	3.72	150,000	558,000	150,000
Jan 30 2020	EVLO	Evelo Biosciences, ...	McHale Duncan	Chief Medical Offic ...	Option Exercise	A	7.06	117,000	826,020	117,000
Jan 30 2020	EVLO	Evelo Biosciences, ...	Char Daniel	General Counsel	Option Exercise	A	7.06	35,000	247,100	35,000
Jan 30 2020	EVLO	Evelo Biosciences, ...	Bodmer Mark	CSO, President of R ...	Option Exercise	A	7.06	100,000	706,000	100,000
Jan 30 2020	EVLO	Evelo Biosciences, ...	GILL SIMBA	President & CEO	Option Exercise	A	7.06	250,000	1,765,000	250,000
Jan 30 2020	EVLO	Evelo Biosciences, ...	Poole Jonathan	CFO	Option Exercise	A	7.06	48,000	338,880	48,000
Jan 30 2020	EVLO	Evelo Biosciences, ...	Poole Jonathan	CFO	Option Exercise	A	7.06	106,000	748,360	106,000
Dec 06 2019	EVLO	Evelo Biosciences, ...	Andres Juan	Director	Option Exercise	A	4.44	31,380	139,327	31,380
Sep 17 2019	EVLO	Evelo Biosciences, ...	Epstein David R	Director	Option Exercise	A	7.93	75,000	594,750	75,000
Sep 17 2019	EVLO	Evelo Biosciences, ...	Epstein David R	Director	Option Exercise	A	7.93	75,000	594,750	75,000
Jun 14 2019	EVLO	Evelo Biosciences, ...	Gutierrez-Ramos Jose-Carlos	Director	Option Exercise	A	7.07	31,380	221,857	31,380
Jun 13 2019	EVLO	Evelo Biosciences, ...	AFEYAN NOUBAR	Director	Option Exercise	A	7.07	15,690	110,928	15,690
Jun 13 2019	EVLO	Evelo Biosciences, ...	PERRY DAVID P	Director	Option Exercise	A	7.07	15,690	110,928	15,690
Jun 13 2019	EVLO	Evelo Biosciences, ...	Epstein David R	Director	Option Exercise	A	7.07	15,690	110,928	15,690
Jun 13 2019	EVLO	Evelo Biosciences, ...	Darzi Lord Ara	Director	Option Exercise	A	7.07	15,690	110,928	15,690
Jun 13 2019	EVLO	Evelo Biosciences, ...	Simonian Nancy A	Director	Option Exercise	A	7.07	15,690	110,928	15,690
Jun 13 2019	EVLO	Evelo Biosciences, ...	MELAS KYRIAZI THEO	Director	Option Exercise	A	7.07	15,690	110,928	15,690
Jan 16 2019	EVLO	Evelo Biosciences, ...	Bodmer Mark	CSO, President of R ...	Option Exercise	A	13.71	100,000	1,371,000	100,000
Jan 16 2019	EVLO	Evelo Biosciences, ...	GILL SIMBA	President & CEO	Option Exercise	A	13.71	220,000	3,016,200	220,000
Jan 16 2019	EVLO	Evelo Biosciences, ...	Poole Jonathan	CFO	Option Exercise	A	13.71	100,000	1,371,000	100,000
Nov 01 2018	EVLO	Evelo Biosciences, ...	Char Daniel	General Counsel	Option Exercise	A	9.11	100,000	911,000	100,000
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	4,643,963	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	18,611,110	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	8,333,000	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	5,416,667	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	10,102,055	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	12,536,945	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	16.00	281,250	4,500,000	18,233,403	18 M to 18.2 M (+1.57 %)
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	C	0.00	14,622,143	0	17,952,153	3.3 M to 18 M (+439.10 %)
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund V Gener ...	10% Owner	Option Exercise	C	0.00	4,643,963	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund V Gener ...	10% Owner	Option Exercise	C	0.00	18,611,110	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund V Gener ...	10% Owner	Option Exercise	C	0.00	8,333,000	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund V Gener ...	10% Owner	Option Exercise	C	0.00	5,416,667	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund V Gener ...	10% Owner	Option Exercise	C	0.00	10,102,055	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund V Gener ...	10% Owner	Option Exercise	C	0.00	12,536,945	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund V Gener ...	10% Owner	Buy	P	16.00	281,250	4,500,000	18,233,403	18 M to 18.2 M (+1.57 %)
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund V Gener ...	10% Owner	Buy	C	0.00	14,622,143	0	17,952,153	3.3 M to 18 M (+439.10 %)
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	4,643,963	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	18,611,110	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	8,333,000	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	5,416,667	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	10,102,055	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Option Exercise	C	0.00	12,536,945	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	P	16.00	281,250	4,500,000	18,233,403	18 M to 18.2 M (+1.57 %)
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund IV Gene ...	10% Owner	Buy	C	0.00	14,622,143	0	17,952,153	3.3 M to 18 M (+439.10 %)
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund V Gener ...	10% Owner	Option Exercise	C	0.00	4,643,963	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund V Gener ...	10% Owner	Option Exercise	C	0.00	18,611,110	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund V Gener ...	10% Owner	Option Exercise	C	0.00	8,333,000	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund V Gener ...	10% Owner	Option Exercise	C	0.00	5,416,667	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund V Gener ...	10% Owner	Option Exercise	C	0.00	10,102,055	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund V Gener ...	10% Owner	Option Exercise	C	0.00	12,536,945	0	0
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund V Gener ...	10% Owner	Buy	P	16.00	281,250	4,500,000	18,233,403	18 M to 18.2 M (+1.57 %)
May 15 2018	EVLO	Evelo Biosciences, ...	Flagship Ventures Fund V Gener ...	10% Owner	Buy	C	0.00	14,622,143	0	17,952,153	3.3 M to 18 M (+439.10 %)
May 10 2018	EVLO	Evelo Biosciences, ...	Poole Jonathan	CFO	Option Exercise	A	16.00	71,497	1,143,952	71,497
May 10 2018	EVLO	Evelo Biosciences, ...	GILL SIMBA	President & CEO	Option Exercise	A	16.00	145,869	2,333,904	145,869
May 10 2018	EVLO	Evelo Biosciences, ...	McHale Duncan	Chief Medical Offic ...	Option Exercise	A	16.00	79,052	1,264,832	79,052
May 10 2018	EVLO	Evelo Biosciences, ...	Bodmer Mark	See Remarks	Option Exercise	A	16.00	55,437	886,992	55,437
May 10 2018	EVLO	Evelo Biosciences, ...	Simonian Nancy A	Director	Option Exercise	A	16.00	31,380	502,080	31,380

Page: 1